Literature DB >> 17935492

ATF2 on the double - activating transcription factor and DNA damage response protein.

Anindita Bhoumik1, Pablo Lopez-Bergami, Ze'ev Ronai.   

Abstract

Signal transduction pathways play a key role in the regulation of key cellular processes, including survival and death. Growing evidence points to changes in signaling pathway that occur during skin tumor development and progression. Such changes impact the activity of downstream substrates, including transcription factors. The activating transcription factor 2 (ATF2) has been implicated in malignant and non-malignant skin tumor developments. ATF2 mediates both transcription and DNA damage control, through its phosphorylation by JNK/p38 or ATM/ATR respectively. Here, we summarize our present understanding of ATF2 regulation, function and contribution to malignant and non-malignant skin tumor development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17935492      PMCID: PMC2997391          DOI: 10.1111/j.1600-0749.2007.00414.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  89 in total

1.  Selective DNA bending by a variety of bZIP proteins.

Authors:  T K Kerppola; T Curran
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

2.  A heteromeric protein that binds to a meiotic homologous recombination hot spot: correlation of binding and hot spot activity.

Authors:  W P Wahls; G R Smith
Journal:  Genes Dev       Date:  1994-07-15       Impact factor: 11.361

Review 3.  Modulation of AP-1/ATF transcription factor activity by the adenovirus-E1A oncogene products.

Authors:  B M Hagmeyer; P Angel; H van Dam
Journal:  Bioessays       Date:  1995-07       Impact factor: 4.345

4.  Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site.

Authors:  T Nakamura; S Okuyama; S Okamoto; T Nakajima; S Sekiya; K Oda
Journal:  Exp Cell Res       Date:  1995-02       Impact factor: 3.905

5.  Transcription factor ATF2 regulation by the JNK signal transduction pathway.

Authors:  S Gupta; D Campbell; B Dérijard; R J Davis
Journal:  Science       Date:  1995-01-20       Impact factor: 47.728

6.  Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice.

Authors:  A M Reimold; M J Grusby; B Kosaras; J W Fries; R Mori; S Maniwa; I M Clauss; T Collins; R L Sidman; M J Glimcher; L H Glimcher
Journal:  Nature       Date:  1996-01-18       Impact factor: 49.962

7.  Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements.

Authors:  W Du; D Thanos; T Maniatis
Journal:  Cell       Date:  1993-09-10       Impact factor: 41.582

8.  ATF-2 contains a phosphorylation-dependent transcriptional activation domain.

Authors:  C Livingstone; G Patel; N Jones
Journal:  EMBO J       Date:  1995-04-18       Impact factor: 11.598

9.  ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents.

Authors:  H van Dam; D Wilhelm; I Herr; A Steffen; P Herrlich; P Angel
Journal:  EMBO J       Date:  1995-04-18       Impact factor: 11.598

10.  Schizosaccharomyces pombe atf1+ encodes a transcription factor required for sexual development and entry into stationary phase.

Authors:  T Takeda; T Toda; K Kominami; A Kohnosu; M Yanagida; N Jones
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  35 in total

1.  T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways.

Authors:  Kohei Hosokawa; Sachiko Kajigaya; Keyvan Keyvanfar; Wangmin Qiao; Yanling Xie; Danielle M Townsley; Xingmin Feng; Neal S Young
Journal:  J Immunol       Date:  2017-06-19       Impact factor: 5.422

Review 2.  Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Authors:  Pablo Lopez-Bergami; Eric Lau; Ze'ev Ronai
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

3.  Strigolactones: a novel class of phytohormones that inhibit the growth and survival of breast cancer cells and breast cancer stem-like enriched mammosphere cells.

Authors:  C B Pollock; H Koltai; Y Kapulnik; C Prandi; R I Yarden
Journal:  Breast Cancer Res Treat       Date:  2012-03-29       Impact factor: 4.872

4.  ATF2 partly mediated the expressions of proliferative factors and inhibited pro-inflammatory factors' secretion in arsenite-treated human uroepithelial cells.

Authors:  Shengnan Liu; Fei Wang; Jieyu Liu; Peiyu Jin; Xiaoyan Wang; Li Yang; Shuhua Xi
Journal:  Toxicol Res (Camb)       Date:  2017-03-29       Impact factor: 3.524

Review 5.  p38 MAP kinases in the heart.

Authors:  Tomohiro Yokota; Yibin Wang
Journal:  Gene       Date:  2015-09-20       Impact factor: 3.688

6.  Ku regulates signaling to DNA damage response pathways through the Ku70 von Willebrand A domain.

Authors:  Victoria L Fell; Caroline Schild-Poulter
Journal:  Mol Cell Biol       Date:  2011-10-28       Impact factor: 4.272

7.  Crosstalk between TGF-beta and MAPK signaling during corneal wound healing.

Authors:  Kazuto Terai; Mindy K Call; Hongshan Liu; Shizuya Saika; Chia-Yang Liu; Yasuhito Hayashi; Tai-ichiro Chikama; Jianhua Zhang; Noriko Terai; Candace W-C Kao; Winston W-Y Kao
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-17       Impact factor: 4.799

8.  Inhibition of melanoma growth by small molecules that promote the mitochondrial localization of ATF2.

Authors:  Tal Varsano; Eric Lau; Yongmei Feng; Marine Garrido; Loribelle Milan; Susanne Heynen-Genel; Christian A Hassig; Ze'ev A Ronai
Journal:  Clin Cancer Res       Date:  2013-04-15       Impact factor: 12.531

9.  Proteomic analysis of the balance between survival and cell death responses in cisplatin-mediated ototoxicity.

Authors:  Samson Jamesdaniel; Dalian Ding; Mohammad Habiby Kermany; Bruce A Davidson; Paul R Knight; Richard Salvi; Donald E Coling
Journal:  J Proteome Res       Date:  2008-06-26       Impact factor: 4.466

10.  Radiation Sensitivity and Tumor Susceptibility in ATM Phospho-Mutant ATF2 Mice.

Authors:  Shuangwei Li; Sergei Ezhevsky; Antimone Dewing; Matthew H Cato; Marzia Scortegagna; Anindita Bhoumik; Wolfgang Breitwieser; Demetrious Braddock; Alexey Eroshkin; Jianfei Qi; Meifan Chen; Jae-Young Kim; Stephen Jones; Nic Jones; Robert Rickert; Ze'ev A Ronai
Journal:  Genes Cancer       Date:  2010-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.